EUCTR2006-002262-19-NL进行中（未招募）1 期
Angiotensin II receptor blockers in patients with systemic right ventricle.
ovartis Pharma B.V.0 个研究点目标入组 0 人开始时间: 2006年6月15日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •All adult patients with a systemic right ventricle due to a congenitally or surgically corrected transposition of the great arteries are potentially eligible for this study
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Incapable of giving informed consent
- •Hypersensitivity to valsartan or any of its help substances
- •Known bilateral renal artery stenosis
- •Current symptomatic hypotension
- •Myocardial infarction, stroke or open-heart surgery in the previous four weeks
- •Previous heart transplant, or expected heart transplant within the next six months
- •Plasma creatinine level > 250 µmol/L
- •Plasma potassium level > 5,5 mmol/L
- •Pregnant or nursing women (a pregnancy test is offered to every female patient within the fertile age)
- •Desire to have children within the study period
研究者
相似试验
撤回
3 期
Angiotensin II receptor blockers in patients with systemic right ventricles.Transposition of the great arteriescongenitally corrected transposition of the great arteries10010394NL-OMON30035Academisch Medisch Centrum128
已完成
不适用
Angiotensin II Receptor Blockers in patients with systemic right ventriclesISRCTN52352170Academic Medical Center (AMC) (The Netherlands)128
尚未招募
不适用
Angiotensin II receptor blockers in patients with systemic right ventricles.Systemic right ventricle due to a congenitally or surgically corrected transposition of the great arteries.NL-OMON21444Academic Medical CentreMeibergdreef 91105 AZ AmsterdamThe Netherlands128
已完成
4 期
Combination Therapy of Angiotensin II Receptor Blocker and Calcium Channel Blocker Exerts Pleiotropic Therapeutic Effects in Addition to Blood Pressure LoweringHypertensionJPRN-UMIN000002531Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine30
已完成
不适用
Effectiveness of angiotensin II receptor blocker for postoperative atrial fibrillation in patients with open heart surgerypatients of open heart surgery with hypertentionJPRN-UMIN000005377Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine120